Cardiovascular Diseases Clinical Trial
To evaluate how current genetic information about cardiovascular disease susceptibility genes contributes to the prediction of future cardiovascular disease outcomes.
BACKGROUND:
During the 1980s and 1990s, genetic research in cardiovascular disease (CVD), as well as
other common chronic diseases, has been dominated by single gene linkage and association
studies focused on understanding of the genetics of prevalent disease. Rarely have there been
studies of the longitudinal predictive value of these genetic variations. Furthermore, few
studies have attempted to address the complex and high-dimensional genetic reality that
underlies an individual's risk of disease. A crucial next step in CVD genetic research is the
evaluation of the contribution of variations in many genes simultaneously, and their
interactions with traditional risk factors, to the longitudinal prediction of CVD in
individuals and families.
DESIGN NARRATIVE:
The study uses participants from the Rochester Family Heart Study (RFHS) which provides one
of the richest genetic epidemiological resources for this type of study. The RFHS represents
3941 individuals distributed among 552 three- generation pedigrees ascertained without regard
to health status during two phases of collection. Phase I was from 1984 - 1988 and Phase II
was from 1988 - 1991. These participants have extensive demographic, physiological, genetic,
and clinical information measured at baseline. This study builds upon this already
established resource by conducting a longitudinal follow-up of the RFHS participants to
address two central questions: 1) Do measured genetic variations in known susceptibility
genes provide additional predictive information about risk of future CVD outcomes beyond the
information provided by more traditional risk factors? and 2) Do these measured genetic
variations explain patterns of disease aggregation in families and can these patterns be used
to predict disease in future generations?
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|